Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Omthera Pharmaceuticals, Inc. in Connection with Sale of Company to AstraZeneca Plc

AZNCF
OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Omthera Pharmaceuticals, Inc. in Connection with Sale of Company to AstraZeneca Plc

NEW YORK, May 30, 2013 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Omthera Pharmaceuticals, Inc. ("Omthera" or the "Company") (NasdaqGM: OMTH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AstraZeneca Plc (NYSE: AZN).

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Click here to learn more about the investigation http://zlk.9nl.com/omthera-pharamaceuticals-omth/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Omthera shareholders will receive $12.70 for each share of Omthera stock they own. In addition, Omthera shareholders will receive approximately $4.70 in contingent value rights if certain benchmarks are met. Including the contingent rights, the transaction has a total approximate value of $443 million. The investigation concerns whether the Omthera Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, whether AstraZeneca is underpaying for Omthera stock, thus unlawfully harming Omthera shareholders.

If you own common stock in Omthera and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/omthera-pharamaceuticals-omth/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today